Research Paper Volume 16, Issue 3 pp 2457—2474

MRPS23 is a novel prognostic biomarker and promotes glioma progression


Figure 3. MRPS23 may act as a potential biomarker in pan-cancer. Predictive power for prognosis with MRPS23 expression by ROC curve analysis in BLCA, CESC, CHOL, and COAD (A); COADREAD, DLBC, GBM, and glioma (B); HNSC, KIRP, LAML, and LIHC (C); LUAD, LUSC, OSCC, and OV (D); PAAD, READ, SKCM, and STAD (E), TGCT, THCA, THYM, and UCS (F).